You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
|
|---|---|
| Published in |
PLOS ONE, August 2010
|
| DOI | 10.1371/journal.pone.0012140 |
| Pubmed ID | |
| Authors |
Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford, Louise R. Simard, Sandra P. Reyna, Kristin J. Krosschell, Gyula Acsadi, Bakri Elsheik, Mary K. Schroth, Guy D'Anjou, Bernard LaSalle, Thomas W. Prior, Susan L. Sorenson, Jo Anne Maczulski, Mark B. Bromberg, Gary M. Chan, John T. Kissel |
| Abstract |
Valproic acid (VPA) has demonstrated potential as a therapeutic candidate for spinal muscular atrophy (SMA) in vitro and in vivo. |
Mendeley readers
The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Germany | 1 | <1% |
| Netherlands | 1 | <1% |
| Ireland | 1 | <1% |
| France | 1 | <1% |
| Spain | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 174 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 30 | 16% |
| Other | 23 | 13% |
| Student > Ph. D. Student | 23 | 13% |
| Student > Master | 23 | 13% |
| Student > Bachelor | 19 | 10% |
| Other | 19 | 10% |
| Unknown | 45 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 21% |
| Neuroscience | 18 | 10% |
| Agricultural and Biological Sciences | 17 | 9% |
| Biochemistry, Genetics and Molecular Biology | 16 | 9% |
| Nursing and Health Professions | 10 | 5% |
| Other | 33 | 18% |
| Unknown | 49 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2023.
All research outputs
#5,302,467
of 24,909,203 outputs
Outputs from PLOS ONE
#83,325
of 215,888 outputs
Outputs of similar age
#21,624
of 100,457 outputs
Outputs of similar age from PLOS ONE
#308
of 825 outputs
Altmetric has tracked 24,909,203 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 215,888 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 100,457 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 825 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.